← Eichor
Study identifier: NCT07367126 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Neuropathic Pain in Knee Osteoarthritis: Pain Severity and Functional Status

Condition: Knee Osteoarthristis  ·  Sponsor: Istanbul Physical Medicine Rehabilitation Training and Research Hospital

PhaseN/A
Planned participants102
Who can joinAll sexes, 40 Years to 70 Years
Healthy volunteersNo

About this study

Osteoarthritis (OA) is a degenerative joint disease characterized by structural changes such as cartilage loss and osteophyte formation, leading to functional limitations and disability. Pain in knee OA involves a complex pathophysiological structure including both nociceptive and neuropathic mechanisms. Identifying the neuropathic pain component is clinically significant for improving quality of life and functional recovery. This cross-sectional controlled clinical study aims to determine the prevalence of neuropathic pain in patients with knee OA and evaluate its impact on pain severity and functional status. Patients will be categorized based on the Douleur Neuropathique 4 (DN4) questionnaire and assessed using various pain and functional scales.

This description comes directly from the study's public registry record.

Talk to the study team

Eser Kalaoglu, M.D.  ·  +90 (212) 496 50 00  ·  eserkalaoglu@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Istanbul Physical Medicine and Rehabilitation Training and Research HospitalIstanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07367126